Can You Start Hormone Therapy After Menopause?

The short answer

For many women, yes — starting hormone therapy after menopause is still an option worth discussing with a qualified provider. The idea that HRT is only for women in the first year or two of menopause is an oversimplification. Age, time since menopause, health history, and the specific therapy all matter to the decision.

On February 12, 2026, the FDA approved labeling changes for six menopausal hormone therapy products, removing cardiovascular disease, breast cancer and probable dementia statements from their boxed warnings. Other warnings and risks remain; this does not mean all hormone products are FDA-approved or risk-free.

Source: FDA announcement, February 12, 2026

Where the fear came from

In 2002, early results from the Women's Health Initiative (WHI) were widely reported as showing that hormone therapy caused serious harm. Prescriptions dropped almost overnight. What was less widely reported: the average participant was around 63 years old — more than a decade past the typical onset of menopause — and many were started on a single specific regimen.

Later reanalyses of the same data told a more nuanced story, particularly for women who began therapy closer to the onset of menopause. Those analyses help explain why treatment decisions consider both age and time since menopause. The February 2026 labeling changes apply to six products; other warnings and risks remain.

The "window of opportunity"

Researchers often describe a window of opportunity — roughly the first 10 years after menopause, or before age 60 — when the benefit-to-risk balance of starting systemic hormone therapy tends to look most favorable for otherwise healthy women. Inside that window, HRT is generally considered a reasonable option to discuss for bothersome symptoms and long-term concerns like bone loss.

Outside that window, the conversation gets more individualized — it doesn't automatically become a "no." Factors like your symptoms, cardiovascular health, breast history, personal risk tolerance, and the type and route of therapy (for example, a transdermal estrogen versus an oral one, or vaginal-only estrogen for local symptoms) all matter.

"I'm years past menopause. Is it too late?"

Not necessarily. Many women who were quietly discouraged from HRT in the years after 2002 are now re-opening the conversation. Some may still be candidates for systemic therapy; others may benefit more from targeted options like low-dose vaginal estrogen for genitourinary symptoms, which has a very different risk profile than systemic HRT.

The important shift is this: the decision belongs in a real conversation with a provider who understands current menopause care and your individual risk factors.

What to do next

• Book a complimentary consultation to discuss Hormone Bliss program options.
• After booking, complete the existing Symptom Scan, then meet your advisor. The consultation does not diagnose a condition or guarantee treatment or results.
• Bring questions about the window of opportunity and the different typesand routes of hormone therapy to a qualified healthcare provider.

This guide is educational and not medical advice. Decisions about hormone therapy should be made with a qualified healthcare provider familiar with your history.